Research news can feel hard to follow. Here is the short, simple version of a story from this week.
What happened
On November 17, 2026, WashU Medicine in St. Louis shared that the National Institute on Aging, part of the NIH, is giving $43 million over five years to keep a very important Alzheimer’s study going. The study is called the Dominantly Inherited Alzheimer Network Observational Study, or DIAN Obs. You can read the original story on the WashU Medicine news site.
What is the DIAN study?
Some families carry a rare gene change that causes Alzheimer’s disease at a young age. A child of an affected parent has a 50% chance of inheriting it. The study began in 2008 and follows these families over many years. More than 750 people have joined so far. The team is based at WashU Medicine, with partners across the U.S. and in 10 other countries.
Everyone gets the same memory tests, brain scans, and blood and spinal fluid checks, whether or not they carry the gene change. About three out of four people had no symptoms when they joined. That lets scientists see what changes in the body long before memory problems begin.
What is new
- Double the people. The new money will double the number of people in the study.
- Look at the lucky ones. Some people carry the gene change but stay healthy far longer than expected. Scientists want to learn what protects them.
- Long-term follow up. The team will track what happens when amyloid, a sticky protein linked to Alzheimer’s, stays cleared from the brain for years.
- Future treatments. They are getting ready for medicines that target the genes behind the disease.
- Comparison group. People treated with amyloid immunotherapy, some for more than 10 years, will be compared with those who were not treated.
Why it matters for everyday labs
Big studies like this run on small daily lab tasks: labeling tubes, storing blood and spinal fluid samples, and keeping everything cold and clean. Good supplies make that work smoother. See tubes and cryogenic vials in the Laboes shop.
Frequently Asked Questions (FAQ)
What is the DIAN study?
It follows families that carry rare gene changes that cause Alzheimer’s disease early in life, so scientists can study the disease before symptoms start.
Who is paying for it?
The National Institute on Aging, part of the NIH, awarded $43 million over five years.
How many people are in the study?
More than 750 people have joined so far, and the new funding is meant to double that number.
Why does this matter to labs?
Long studies like this depend on steady lab work: blood tests, spinal fluid tests and careful sample storage.
Source: WashU Medicine, November 17, 2026. This post is a plain-language summary and is not medical advice.
